Quantcast
The MFWire
Manage Email Alerts | Sponsorships | About MFWire | Who We Are

Subscribe to MFWire.com's News Alerts [click]

Rating:Healthcare PM Team Writes New Prescription for Forward Not Rated 0.0 Email Routing List Email & Route  Print Print
Tuesday, October 16, 2012

Healthcare PM Team Writes New Prescription for Forward

Reported by Tommy Fernandez

San Francisco fund manager Forward Management [profile] has hired a global healthcare investment team away from Asymmetry Capital Management.

The team includes portfolio manager Scott Kay, who was a founding partner at Asymmetry Capital Management as well as, previously, a founding partner at Partner Fund Management, where he served as therapeutic sector head. Before that, he had been a senior healthcare analyst at Andor Capital Management, and at Bank America Securities. Earlier in his career he held various roles in marketing, sales and operations at Pfizer Inc. .

Kay brings two senior analysts, who previously worked with him, to Forward.

Also joining the team is Chris Zellner, who will be responsible for operations and business development.   He brings to the team two decades of global markets and investment banking experience with Bank of America Merrill Lynch, Lehman Brothers and Morgan Stanley, among others.




Company Press Release

Forward Adds Dedicated Healthcare Investment Team



San Francisco, Oct. 16, 2012 -- Forward (Forward Management, LLC) has announced the addition of the Asymmetry global healthcare team. The firm plans to offer a long/short equity strategy investing globally across all healthcare sectors and market capitalizations, in early 2013.

"This new team adds an important and exciting dimension to Forward's investment capabilities. Much like the technology sector, healthcare is a fast-growing, rapidly changing industry that is experiencing a variety of disruptions. For managers who understand the industry's dynamics, this translates into a multitude of long and short investment opportunities," said Alan Reid, CEO of Forward.  

Scott Kay is the portfolio manager for the team. A 20-year healthcare industry veteran, Scott was a founding partner at Partner Fund Management, LP, where he was therapeutic sector head. Previously he was a senior healthcare analyst at Andor Capital Management, LLC and at Bank America Securities, where he was ranked among top healthcare analysts by Institutional Investor. Earlier in his career he held various roles in marketing, sales and operations at Pfizer.

Also joining the team is Chris Zellner, who will be responsible for operations and business development.   He brings to the team two decades of global markets and investment banking experience with Bank of America Merrill Lynch, Lehman Brothers and Morgan Stanley, among others. Two senior analysts, both of whom have previously worked with Scott, will round out the team.   

About Forward

?The world has changed, leading investors to seek new strategies that better fit an evolving global climate. Forward's investment solutions are built around the outcomes we believe investors need to be pursuing - non-correlated return, investment income, global exposure and diversification. With a propensity for unbounded thinking, we focus especially on developing innovative alternative strategies that may help investors build all-weather portfolios. An independent, privately held firm founded in 1998, Forward (Forward Management, LLC) is the advisor to the Forward Funds. As of September 30, 2012, we manage $5.7 billion in a diverse product set offered to individual investors, financial advisors and institutions. More information on Forward can be found at www.forwardinvesting.com.  

Stay ahead of the news ... Sign up for our email alerts now
CLICK HERE

0.0
 Do You Recommend This Story?



GO TO: MFWire
Return to Top
 News Archives
2024: Q2Q1
2023: Q4Q3Q2Q1
2022: Q4Q3Q2Q1
2021: Q4Q3Q2Q1
2020: Q4Q3Q2Q1
2019: Q4Q3Q2Q1
2018: Q4Q3Q2Q1
2017: Q4Q3Q2Q1
2016: Q4Q3Q2Q1
2015: Q4Q3Q2Q1
2014: Q4Q3Q2Q1
2013: Q4Q3Q2Q1
2012: Q4Q3Q2Q1
2011: Q4Q3Q2Q1
2010: Q4Q3Q2Q1
2009: Q4Q3Q2Q1
2008: Q4Q3Q2Q1
2007: Q4Q3Q2Q1
2006: Q4Q3Q2Q1
2005: Q4Q3Q2Q1
2004: Q4Q3Q2Q1
2003: Q4Q3Q2Q1
2002: Q4Q3Q2Q1
 Subscribe via RSS:
Raw XML
Add to My Yahoo!
follow us in feedly


  1. WE Boston - Women's Initiative Joint Spring Networking Reception, May 15
  2. MFDF In Focus: Making Sense of ESG - A Morningstar Guide, May 16
  3. SEC IM 2024 Conference on Emerging Trends in Asset Management, May 16
  4. ALFI Roadshow to the USA, May 16
  5. 2024 ICI Leadership Summit, May 21-23
  6. MFDF webinar - Mutual Fund Director Compensation: the MPI Annual Survey (2024), May 21
  7. Schwab Institutional Investor Day, May 22
  8. MFDF Conference of Fund Leaders Forum, June 5
  9. MFDF in-person outreach: Continuing Regulatory Impacts on Fund Boards, June 11
  10. MFDF webinar - Digital Assets in the Fund Space (Part 1 of 2), June 12
  11. 2024 MMI Leadership Pathway Seminar, Jun 12-14
  12. 2024 Nicsa Fearless Leadership Symposium, June 12
  13. MFDF webinar - Lessons Learned from the Regional Bank Volatility and the Impact on Registered Funds, June 18
  14. MFDF Director Discussion Series - Open Forum (Philadelphia), June 20
  15. New York YPEM Cornhole Classic, June 25
  16. Morningstar Investment Conference Conference 2024, Jun 26-27
  17. MFDF webinar - Mid-Year Tax Update for Registered Investment Companies, July 16
  18. MFDF Director Discussion Series - Open Forum via Zoom, July 17
  19. MFDF Director Discussion Series - Open Forum (New York), July 23
  20. 2024 MMI Annual Conference, Oct 15-17
  21. 5th Annual ETFGI Global ETFs Insight Summit, October 29
  22. MFDF webinar - Digital Assets in the Fund Space (part 2 of 2), November 7
  23. MFDF 2025 Directors' Institute, January 27 - 29, 2025
  24. MFDF 2025 Fund Governance & Regulatory Insights Conference, March 6 - 7, 2025




©All rights reserved to InvestmentWires, Inc. 1997-2024
14 Wall Street | 20th Floor | New York, NY 10005 | P: 212-331-8968 | F: 212-331-8998
Privacy Policy :: Terms of Use